Matches in Nanopublications for { ?s ?p "[In contrast to EBV(+) PTLD which expresses the immunodominant EBV latency III EBNA3A/B/C proteins, EBV(+) cHL is restricted to the subdominant EBNA1/LMP1/LMP2 proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP1267490.RASehf2fcAOsJVWohm9GqRX8EphborBXBQI_iZjdGRg7Y130_assertion description "[In contrast to EBV(+) PTLD which expresses the immunodominant EBV latency III EBNA3A/B/C proteins, EBV(+) cHL is restricted to the subdominant EBNA1/LMP1/LMP2 proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267490.RASehf2fcAOsJVWohm9GqRX8EphborBXBQI_iZjdGRg7Y130_provenance.
- NP1267494.RARBGyw8tpVI36HEhm4uhjEKz3_3nRIYvDej_EaYRhPk4130_assertion description "[In contrast to EBV(+) PTLD which expresses the immunodominant EBV latency III EBNA3A/B/C proteins, EBV(+) cHL is restricted to the subdominant EBNA1/LMP1/LMP2 proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267494.RARBGyw8tpVI36HEhm4uhjEKz3_3nRIYvDej_EaYRhPk4130_provenance.
- NP1267492.RALAZxwSL_CHTkFQgVYIxVeS94VpvGTe9EoUA37x6y8nI130_assertion description "[In contrast to EBV(+) PTLD which expresses the immunodominant EBV latency III EBNA3A/B/C proteins, EBV(+) cHL is restricted to the subdominant EBNA1/LMP1/LMP2 proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267492.RALAZxwSL_CHTkFQgVYIxVeS94VpvGTe9EoUA37x6y8nI130_provenance.
- NP1267491.RA2cTW-SHQhtMKBhTuOVB6SRr3okifSZxYkGpjEFqlTfw130_assertion description "[In contrast to EBV(+) PTLD which expresses the immunodominant EBV latency III EBNA3A/B/C proteins, EBV(+) cHL is restricted to the subdominant EBNA1/LMP1/LMP2 proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267491.RA2cTW-SHQhtMKBhTuOVB6SRr3okifSZxYkGpjEFqlTfw130_provenance.